These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34568129)

  • 21. [Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].
    Chen L; Zhang A; Li Q; Cui Y; Yuan G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):399-404. PubMed ID: 34053480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early hematological indicators of severe COVID-19 disease in hospitalized patients: Data from a South Asian population.
    Sharif F; Khan S; Junaid A; Jahangir S; Saeed M; Ijaz M; Ahmad IN; Kamran S
    Int J Lab Hematol; 2021 Oct; 43(5):1237-1242. PubMed ID: 33837662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune cell profiling and antibody responses in patients with COVID-19.
    Rezaei M; Mahmoudi S; Mortaz E; Marjani M
    BMC Infect Dis; 2021 Jul; 21(1):646. PubMed ID: 34225645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematological changes associated with COVID-19 infection.
    Al-Saadi EAKD; Abdulnabi MA
    J Clin Lab Anal; 2022 Jan; 36(1):e24064. PubMed ID: 34783405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematological and other Laboratory Parameter Changes in COVID-19 Patients.
    Khatib Y; Samele R; Chaudhari J; Khare M; Gupte P; Sable Y; Shah V
    J Assoc Physicians India; 2023 Apr; 71(4):11-12. PubMed ID: 37355788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4
    Mahmoudi S; Yaghmaei B; Sharifzadeh Ekbatani M; Pourakbari B; Navaeian A; Parvaneh N; Haghi Ashtiani MT; Mamishi S
    Front Pediatr; 2021; 9():643299. PubMed ID: 33937149
    [No Abstract]   [Full Text] [Related]  

  • 28. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
    Zhao R; Sun Y; Zhang Y; Wang W; Wang S; Wang C; Liu J; Gao L; Hu Z; Fei J; Hou X; Zheng H; Chen L
    Mediators Inflamm; 2020; 2020():6914878. PubMed ID: 33061829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between COVID-19 Outcomes and Patient Characteristics: A Study in an Inner-City Community Hospital.
    Almonte M; Au XY; Ali M; Rajabalee N; Hasan S; Shibre T; Li Y; Kaplan AC
    Cureus; 2021 Aug; 13(8):e17255. PubMed ID: 34540480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of hematological, coagulation and inflammatory biomarker's role in predicting the severity of disease in patients with COVID-19, admitted in designated COVID-19 hospital of central India.
    Lokwani DP; Yadav BS; Bharti S; Gupta V; Toppo N
    Indian J Pathol Microbiol; 2021; 64(4):735-740. PubMed ID: 34673594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematological Abnormalities in COVID-19: A Narrative Review.
    Rahman A; Niloofa R; Jayarajah U; De Mel S; Abeysuriya V; Seneviratne SL
    Am J Trop Med Hyg; 2021 Feb; 104(4):1188-1201. PubMed ID: 33606667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Hematological Parameters in the Grading of COVID-19 and a Model to Predict the Outcome in Inpatients.
    Kumar Y; Kumari A; Kumar T; Jha K; Zabihullah M
    Cureus; 2023 Sep; 15(9):e45276. PubMed ID: 37846240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study.
    Ballini A; Cantore S; Serretiello E; Troiano G; Smimmo A; Dioguardi M; Spirito F; Sasso FC; De Vito D; Lo Muzio L; Di Domenico M
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8962-8974. PubMed ID: 37782206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematological Findings and Alteration of Oxidative Stress Markers in Hospitalized Patients with SARS-COV-2.
    Gjorgjievska K; Petrushevska M; Zendelovska D; Atanasovska E; Spasovska K; Stevanovikj M; Grozdanovski K
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2022 Jul; 43(2):5-13. PubMed ID: 35933163
    [No Abstract]   [Full Text] [Related]  

  • 40. The İmportance of hematological parameters in the prognosis of patients with severe COVID-19, A single-center retrospective study.
    Gozukucuk R; Kılıc HH; Uyanik BS; Cakiroglu B
    Niger J Clin Pract; 2023 Sep; 26(9):1297-1302. PubMed ID: 37794542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.